Florida Cancer Specialists & Research Institute | Association Partnerships

In an interview, Cesar Augusto Perez, MD, delved into the findings from a phase 2 study evaluating petosemtamab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Cesar Augusto Perez, MD, discusses one of the top unmet needs that exists in the thyroid cancer space.

Cesar Augusto Perez, MD, discusses the efficacy data reported in a phase 2 study of petosemtamab plus pembrolizumab for the first-line treatment of patients with recurrent/metastatic head and neck squamous cell carcinoma.

Breaking New Ground in Biological Therapies for Cancer

Findings Published in International Oncology Journal

FCS Disease Site Committee Formed

37 Cutting-Edge Study Results Presented at Global Gathering, Six Oral Presentations.

Florida Cancer Specialists & Research Institute, LLC (FCS) physicians and senior leaders are participating in the Florida Society of Clinical Oncology 2024 Business of Oncology Summit & Spring Session this week in Kissimmee, FL.

In a case study released today by Florida Cancer Specialists & Research Institute, LLC, community oncology practices emerge as the preferred site of service for cancer treatment, challenging the traditional dominance of hospitals and academic centers.

Lucio Gordan, MD Serves on Panel of Oncology Leaders Sharing Insights with Oncology Fellows.

Lucio Gordan, MD will join a panel of industry experts for a discussion of key clinical data and insights in treatment options for newly-diagnosed, transplant ineligible patients diagnosed with multiple myeloma.

Florida Cancer Specialists & Research Institute, LLC medical oncologist and hematologist Ernesto Bustinza-Linares, MD is co-author of a recent abstract published in the American Society of Clinical Oncology Journal, JCO Precision Oncology.

Innovations in patient care developed at Florida Cancer Specialists & Research Institute, LLC will be presented at the Oncology Nursing Society 49th Annual Congress in Washington, DC, the largest global gathering dedicated to oncology nursing.

Florida Cancer Specialists & Research Institute, Core Ventures Turn Vision into Value

Florida Cancer Specialists & Research Institute, LLC, is pleased to announce that medical oncologist and hematologist Jacob L. Barish, MD has joined the statewide practice.

Ribbon-cutting celebrates opening of new Orange City clinic

Also Providing Gynecologic Oncology Care in West Palm Beach

Florida Cancer Specialists & Research Institute Announces Intentions to Explore New Distributor and Group Purchasing Organization Partnerships

Florida Cancer Specialists & Research Institute, LLC is pleased to announce the appointments of Joel Grossman, MD and Maen Hussein, MD to its Executive Board. Dr. Hussein also serves on the Finance Committee.

Florida Cancer Specialists & Research Institute, in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has been granted a 3-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.

Trevor Heritage, PhD presents insights at PMWC® 2024

Program Details & Findings Published in Current Oncology

Bradley J. Monk, MD, FACS, FACOG, discusses the enrollment criteria and dosing for the phase 3 KEYNOTE-A18 study of patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer.

International conference spotlights latest advancements in immunotherapies

New and late-breaking data highlighted at 2023 San Antonio Breast Cancer Symposium®

Research Presented at Global Hematology Symposium

Robin Marshall is an accomplished and well-known media professional, blogger, lead singer, song writer, over-40 model and visual artist. She is also a two-time cancer survivor.

The Florida Cancer Specialists & Research Institute, LLC 2022 Annual Report, produced by the FCS in-house Marketing team, has been recognized in the 4th Annual Healthcare Digital Marketing Awards, a prestigious national awards program that recognizes excellence in healthcare and medical marketing.

Value-based care program offers Florida patients access to high quality cancer care while reducing costs for employers.

Florida Cancer Specialists & Research Institute physicians were recognized in 2023 by their physician peers, patients and residents as top doctors in their local communities for providing world-class treatment for all forms of cancers and blood disorders.